Reuters logo
BRIEF-Tigenix to present positive 52-week Phase III results of Cx601
October 5, 2017 / 5:13 AM / in 13 days

BRIEF-Tigenix to present positive 52-week Phase III results of Cx601

Oct 5 (Reuters) - TIGENIX NV:

* TIGENIX TO PRESENT POSITIVE 52-WEEK PHASE III RESULTS OF CX601 AT WORLD CONGRESS OF GASTROENTEROLOGY AT ACG 2017 MEETING

* THESE DATA HAVE BEEN USED TO FURTHER SUPPORT OUR MARKETING AUTHORISATION APPLICATION FOR TIGENIX, FOR WHICH WE ANTICIPATE A CHMP OPINION IN 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below